Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients

Citation
M. Ooka et al., Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients, ONCOL REP, 7(3), 2000, pp. 561-566
Citations number
31
Categorie Soggetti
Oncology
Journal title
ONCOLOGY REPORTS
ISSN journal
1021335X → ACNP
Volume
7
Issue
3
Year of publication
2000
Pages
561 - 566
Database
ISI
SICI code
1021-335X(200005/06)7:3<561:SOMMFD>2.0.ZU;2-#
Abstract
The aim of this study was to search for specific and sensitive mRNA markers or a combination of markers for RT-PCR detection of micrometastases in axi llary lymph nodes (LNs) from patients with breast cancer. LNs (n=177) from 17 patients were examined with Cytokeratin20 (CK20), melanoma-associated ge nes (MAGE1, MAGE3), carcino-embryonic antigen (CEA), prostate-specific anti gen (PSA), mammaglobin (MGB1) and mammaglobin B (MGB2) as molecular markers . CK20, MAGE1 and MAGE3 were slightly positive in primary tumors and CEA, P SA, MGB1 and MGB2 were highly positive. MGB1 and MGB2 were 100% positive in HE-positive LNs while CEA and PSA were only 35.7% and 57.1% positive. MGB1 and MGB2 were also 30.1% and 17.8% positive in HE-negative nodes. Thus, MG B1 and MGB2 are specific and a combination of the two should be useful for detection of micrometastases in axillary LNs of breast cancer patients.